Interim Report to 30 September 2015 is now available to view via the following link. The PDF report will download automatically when clicked.
Access to AFT FY16 Interim Report

Similar articles
AFT Pharmaceuticals celebrates 20 years of success
Twenty years ago this week, husband and wife Dr Hartley Atkinson and Marree Atkinson, started AFT Pharmaceuticals (AFT) in a room off their home garage.
Read more
AFT Pharmaceutical’s painkiller Maxigesic now licensed in France, the world’s second largest paracetamol and ibuprofen tablet market
AFT Pharmaceuticals (AFT’) has extended its existing agreements to add a French pharmaceutical company to out-license the product line of its patented combination painkiller, Maxigesic, to France, Monaco, Andorra and French dependencies DOM TOMs.1
Read more
Maxigesic® IV licensed in eight new European markets
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces it has signed an exclusive Maxigesic® IV licensing agreement for eight new European markets.
Read more